Regulation of c-fos transcription by chemopreventive isoflavonoids and lignans in MDA-MB-468 breast cancer cells

By Schultze-Mosgau M.-H.   Dale I.L.   Gant T.W.   Chipman J.K.   Kerr D.J.   Gescher A.  

European Journal of Cancer, Vol. 34, Iss. 9, 1998-08 ,pp. : 1425-1431

Elsevier

Access to resources Recommend Favorite

Value of GlutathioneS-Transferase and the Oncogene Products c-Jun, c-Fos, c-H-Ras, and c-Myc as a Prognostic Indicator in Endometrial Carcinomas

By Yokoyama Y.   Sagara M.   Sato S.   Saito Y.  

Gynecologic Oncology, Vol. 68, Iss. 3, 1998-03 ,pp. : 280-287

Elsevier

Access to resources Recommend Favorite

Dual role of AP-2 in ErbB-2-induced mammary tumorigenesis

By Jäger Richard   Friedrichs Nicolaus   Heim Inge   Büttner Reinhard   Schorle Hubert  

Breast Cancer Research and Treatment, Vol. 90, Iss. 3, 2005-04 ,pp. : 273-280

Springer Publishing Company

Access to resources Recommend Favorite

Transcription Factors as Targets for Cancer Therapy: AP-1 a Potential Therapeutic Target

By  

Current Cancer Therapy Reviews, Vol. 3, Iss. 1, 2007-02 ,pp. : 1-6

Bentham Science Publishers

Access to resources Recommend Favorite

Transforming Growth Factor- Negatively Modulates Proliferation and c-fosExpression of the Human Endometrial Adenocarcinoma Cell Line HEC-1-A

By Bergman C.A.   Talavera F.   Christman G.M.   Baker V.V.   Roberts J.A.   Menon K.M.J.  

Gynecologic Oncology, Vol. 65, Iss. 1, 1997-04 ,pp. : 63-68

Elsevier

Access to resources Recommend Favorite